RenovoRx develops RenovoCath, a drug delivery device, and other drug and device combination products for healthcare providers. It last closed at $0.94 on Nov 20, down 10.29% on the day. The next earnings report for RNXT is expected around Mon, Mar 29, 2027, after the close. For the quarter ended Sep 2026, RNXT reported EPS of -$0.08 on revenue of $1.1M, with revenue up 300.8% from a year ago. Over its last 8 reports the stock moved an average of 8.8% the session after earnings. Over the last 12 months RNXT insiders bought $131K of stock on the open market and sold $0, according to SEC Form 4 filings.
AI Auto Pilots
Is RNXT in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold RNXT.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on RNXTStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
RNXT · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, nearing oversold
The stock is 27% below its 20 day and 43% below its 50 day average. It is 18% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 36), near oversold. The nearest support is the Pivot S1 at $0.90, and the nearest resistance the swing high (Jul 27) at $0.98.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityHigh, 15.2%/day
Key levels
$2.5952 week high+175.5%
$1.3550 day average+43.6%
$1.31100 day average+39.4%
$1.2020 day average+27.7%
$1.11200 day average+18.1%
$1.01Pivot R1+7.4%
$0.98Pivot+4.3%
$0.98Swing high (Jul 27)+4.3%
$0.94Last close
$0.90Pivot S1−4.3%
$0.90Swing low (Nov 16)−4.3%
$0.7652 week low−19.1%
Indicators
RSI (14)
35.57
Weak, oversold below 30
Neutral
MACD
-0.09
Below its signal line
Bearish
Stochastic
23.5
Middle of its range
Neutral
ADX (14)
16.0
No clear trend
Williams %R
-90.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-124.3
Oversold below −100, overbought above 100
Oversold
Rate of change
−16.6%
Change over 10 sessions
Bearish
ATR (14)
$0.14
Typical daily range, 15.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 31.2%/day
Key levels
$2.5952 week high+175.5%
$1.3550 day average+43.6%
$1.31100 day average+39.4%
$1.2020 day average+27.7%
$1.11200 day average+18.1%
$1.01Pivot R1+7.4%
$0.98Pivot+4.3%
$0.98Swing high (Jul 27)+4.3%
$0.94Last close
$0.90Pivot S1−4.3%
$0.90Swing low (Nov 16)−4.3%
$0.7652 week low−19.1%
Indicators
RSI (14)
42.62
Middle of its range
Neutral
MACD
0.02
Below its signal line
Bearish
Stochastic
9.2
Near the bottom of its range
Oversold
ADX (14)
27.9
Trending up
Williams %R
-96.4
Oversold below −80, overbought above −20
Oversold
CCI (20)
-77.2
Oversold below −100, overbought above 100
Neutral
Rate of change
−46.5%
Change over 10 sessions
Bearish
ATR (14)
$0.29
Typical daily range, 31.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for RNXT
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how RNXT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow RNXT usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for RNXTHow many large options trades hit RNXT, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in RNXT in the last 90 days.
From SEC Form 4 filings by RNXT's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RNXT is in one of them and how their past RNXT trades turned out.
RenovoRx is a medical device company based in Mountain View, California. It develops RenovoCath, a proprietary drug delivery device sold as a standalone product, along with other products that combine drugs and devices. Its product candidates are still in clinical trials. Its customers are expected to include physicians, hospitals and other healthcare providers, whose care may be paid for by government programs and private insurers.